Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Uchenna Elemuwa · Sankore

National Agency for the Control of AIDS

Uchenna Elemuwa

Name matching only

This profile was assembled from author names on publications. Open indexes routinely split one researcher across several such profiles, so these totals may be incomplete. 1 other profile was folded into this one.

Publications

6

Citations

18

h-index

2

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

1

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Affiliations

Every institution this scholar has appeared with on a work, by how many.

National Agency for the Control of AIDS6 works
National Institute for Pharmaceutical Research and Development2 works
University of Nigeria Teaching Hospital1 works
University of Nigeria1 works

Publications

6 works in the graph, newest first.

Enhanced passive safety surveillance during the first use of the meningococcal vaccine A/C/W/Y/X conjugate for outbreak response in Niger and Nigeria
2026VaccineJournal2 citations10.1016/j.vaccine.2026.128390
Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021
2025VaccineJournalOpen access2 citations10.1016/j.vaccine.2025.126907
Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial
2025Scientific ReportsJournalOpen access2 citations10.1038/s41598-025-06536-2
A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial
2025TrialsJournalOpen access0 citations10.1186/s13063-025-09317-4

Current Practices and Risk Assessment in COVID-19 Vaccine Procurement in Nigeria

2024International Journal of Medical Science and Dental HealthJournalOpen access2 citations10.55640/ijmsdh-10-01-06

A qualitative analysis of the COVID-19 vaccination rollout in Lagos, Nigeria: Client and provider perspectives on the plan, the process and the progress

2022PLOS Global Public HealthJournalOpen access10 citations10.1371/journal.pgph.0000486